NT-proBNP to exclude heart failure in primary care – a pragmatic, cluster-randomized study

References

• Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 1994;90:195–203.
   PubMed Web of Science ®Google Scholar
• Clerico A, Passino C, Franzini M, et al. Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives [Review]. Future Cardiol. 2016;12:573–584.
   PubMed Web of Science ®Google Scholar
• Sergeeva IA, Christoffels VM. Regulation of expression of atrial and brain natriuretic peptide, biomarkers for heart development and disease. Biochim Biophys Acta. 2013;1832:2403–2413.
   PubMed Web of Science ®Google Scholar
• Booth RA, Hill SA, Don-Wauchope A, et al. Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review. Heart Fail Rev. 2014;19:439–451.
   PubMed Web of Science ®Google Scholar
• Mogelvang R, Goetze JP, Schnohr P, et al. Discriminating between cardiac and pulmonary dysfunction in the general population with dyspnea by plasma pro-B-type natriuretic peptide. J Am Coll Cardiol. 2007;50:1694–1701.
   PubMed Web of Science ®Google Scholar
• Hildebrandt P, Collinson PO, Doughty RN, et al. Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care. Eur Heart J. 2010;31:1881–1889.
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18:891–975.
   PubMed Web of Science ®Google Scholar
• Wright SP, Doughty RN, Pearl A, et al. Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial. J Am Coll Cardiol. 2003;42:1793–1800.
   PubMed Web of Science ®Google Scholar
• Rutten FH, Moons KG, Cramer MJ, et al. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ (Clinical Research ed). 2005;331:1379.
   PubMed Web of Science ®Google Scholar
• Nielsen LS, Svanegaard J, Klitgaard NA, et al. N-terminal pro-brain natriuretic peptide for discriminating between cardiac and non-cardiac dyspnoea. Eur J Heart Fail. 2004;6:63–70.
   PubMed Web of Science ®Google Scholar
• Cowie MR, Struthers AD, Wood DA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet. 1997;350:1349–1353.
   PubMed Web of Science ®Google Scholar
• Kelder JC, Cramer MJ, van Wijngaarden J, et al. The diagnostic value of physical examination and additional testing in primary care patients with suspected heart failure. Circulation. 2011;124:2865–2873.
   PubMed Web of Science ®Google Scholar
• Gustafsson F, Steensgaard-Hansen F, Badskjaer J, et al. Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure. J Card Fail. 2005;11:S15–S20.
   PubMed Web of Science ®Google Scholar
• Authority DH. Pakkeforløb for hjertesvigt og hjerteklapsygdom Copenhagen: Sundhedsstyrelsen (Danish Health Authority); 2013 [cited 2013 May 05]. Available from: http://sundhedsstyrelsen.dk/publ/Publ2013/05maj/PkforlHjertesvigtKlapv2.pdf
   Google Scholar
• Cardiology DSo. Kronisk hjertesvigt Copenhagen: Dansk Cardiologisk Selskab (Danish Society of Cardiology); 2017 [cited 2017 Mar 24]. Available from: https://www.nbv.cardio.dk/chf
   Google Scholar
• Brusamento S, Legido-Quigley H, Panteli D, et al. Assessing the effectiveness of strategies to implement clinical guidelines for the management of chronic diseases at primary care level in EU Member States: a systematic review. Health Policy (Amsterdam, Netherlands). 2012;107:168–183.
   PubMed Web of Science ®Google Scholar
• Hancock HC, Close H, Fuat A, et al. Barriers to accurate diagnosis and effective management of heart failure have not changed in the past 10 years: a qualitative study and national survey. BMJ Open. 2014;4:e003866–2013.
   PubMed Web of Science ®Google Scholar
• Nallamothu BK, Hayward RA, Bates ER. Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies. Circulation. 2008;118:1294–1303.
   PubMed Web of Science ®Google Scholar
• CMS CfMMS. Design and Development of the Diagnosis Related Group (DRG) Baltimore (MD): CMS, Centers for Medicare & Medicaid Services; 2016 [cited 2016 Oct 01]. Available from: https://www.cms.gov/ICD10Manual/version34-fullcode-cms/fullcode_cms/Design_and_development_of_the_Diagnosis_Related_Group_(DRGs)_PBL-038.pdf
   Google Scholar
• Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–381.
   PubMed Web of Science ®Google Scholar
• McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Turk Kardiyoloji Dernegi Arsivi: Turk Kardiyoloji Derneginin Yayin Organidir. 2012;40:77–137.
   PubMedGoogle Scholar
• Malterud K. Systematic text condensation: a strategy for qualitative analysis. Scand J Public Health. 2012;40:795–805.
   PubMed Web of Science ®Google Scholar
• Don-Wauchope AC, McKelvie RS. Evidence based application of BNP/NT-proBNP testing in heart failure. Clin Biochem. 2015;48:236–246.
   PubMed Web of Science ®Google Scholar
• Burri E, Hochholzer K, Arenja N, et al. B-type natriuretic peptide in the evaluation and management of dyspnoea in primary care. J Intern Med. 2012;272:504–513.
   PubMed Web of Science ®Google Scholar
• Rutten FH, Cramer MJM, Zuithoff NPA, et al. Comparison of B-type natriuretic peptide assays for identifying heart failure in stable elderly patients with a clinical diagnosis of chronic obstructive pulmonary disease. Eur J Heart Fail. 2007;9:651–659.
   PubMed Web of Science ®Google Scholar
• Kelder JC, Cowie MR, McDonagh TA, et al. Quantifying the added value of BNP in suspected heart failure in general practice: an individual patient data meta-analysis. Heart (British Cardiac Society). 2011;97:959–963.
   PubMed Web of Science ®Google Scholar
• Lim TK, Dwivedi G, Hayat S, et al. Cost effectiveness of the B type natriuretic peptide, electrocardiography, and portable echocardiography for the assessment of patients from the community with suspected heart failure. Echocardiography (Mount Kisco, NY). 2007;24:228–236.
   PubMed Web of Science ®Google Scholar
• Husby S, Lind B, Goetze JP. Practical use of natriuretic peptide measurement: questionnaire results from general practitioners and cardiologists. Biomarkers Med. 2012;6:13–18.
   PubMed Web of Science ®Google Scholar
• Midtjylland R. Stadig flere scannes for hjertesygdom i Region Midtjylland Viborg: Region Midtjylland; 2011 [cited 2011 May 05]. Available from: http://www.rm.dk/om-os/aktuelt/nyheder/News_2011/05-maj/stadig-flere-scannes-for-hjertesygdom-i-region-midtjylland
   Google Scholar
• Mard S, Nielsen FE. Positive predictive value and impact of misdiagnosis of a heart failure diagnosis in administrative registers among patients admitted to a University Hospital cardiac care unit. Clin Epidemiol. 2010;2:235–239.
   PubMedGoogle Scholar